The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Open accessAbstract
Estimates of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC). This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries. The validity of the national estimates depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths. We briefly describe the key results globally and by world region. There were an estimated 18.1 million (95% UI: 17.5–18.7 million) new cases of cancer (17 million excluding non‐melanoma skin cancer) and 9.6 million (95% UI: 9.3–9.8 million) deaths from cancer (9.5 million excluding non‐melanoma skin cancer) worldwide in 2018.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, our country-specific cervical cancer incidence data are based on GLOBOCAN estimates,42, 53 which, where possible, are derived from extrapolation of recent trends in incidence obtained from national or subnational population-based cancer registries.”
From Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries (2020) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova‐Foucher, E., Lortet‐Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,243
Self-citationGlobal burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,634
Self-citationUnited Nations Population Division
Wheldon, M. C., Raftery, A. E., Clark, S. J., & Gerland, P. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_6852 · Cited by 982
Cancer mortality for selected sites in 24 countries
栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 880
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002056 · Cited by 424
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- Bray F, 2017, Cancer incidence in five continents
- World Health Organization (WHO), 2017, Mortality Database Health statistics and information systems
- World Health Statistics, 2017, Monitoring health for the SDGs, sustainable development goals, 2017
Cited by
Sorted by citations
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationBray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Self-citationCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 6,308
Self-citationHead and neck squamous cell carcinoma
Johnson, D. E., Burtness, B. A., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,458
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30482-6 · Cited by 4,465
Self-citationCurrent and future burden of breast cancer: Global statistics for 2020 and 2040
Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., et al. (2022) · The Breast · doi:10.1016/j.breast.2022.08.010 · Cited by 3,411
Self-citationGlobal burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Morgan, E., Arnold, M., Gini, A., Lorenzoni, V, Cabasag, C. J., Laversanne, M., Vignat, J., Ferlay, J., Murphy, N., & Bray, F. (2023) · Gut · doi:10.1136/gutjnl-2022-327736 · Cited by 2,429
Self-citationGlobal burden of cancer attributable to infections in 2018: a worldwide incidence analysis
de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475
Self-citationCancer incidence and mortality in China, 2016
Zheng, R., Sun, K., Han, B., Li, L., Chen, R., Wang, S., Li, L., Zeng, H., He, J., Wei, W., et al. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.02.002 · Cited by 1,516
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., Cust, A. E., de Vries, E., Whiteman, D. C., & Bray, F. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.0160 · Cited by 1,539
Self-citationAdvances in immunotherapy for hepatocellular carcinoma
Sangro, B., Sarobe, P., Hervás-Stubbs, S., & Melero, I. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00438-0 · Cited by 1,306
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Klein, A. P. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00457-x · Cited by 1,258
Morgan, E., Soerjomataram, I., Rumgay, H., Coleman, H. G., Thrift, A. P., Vignat, J., Laversanne, M., Ferlay, J., & Arnold, M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.054 · Cited by 1,242
Self-citationRebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,238
The global burden of urinary bladder cancer: an update
Richters, A., Aben, K. K. H., & Kiemeney, L. A. L. M. (2019) · World Journal of Urology · doi:10.1007/s00345-019-02984-4 · Cited by 972
Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 943
Self-citationMiranda‐Filho, A., Laversanne, M., Ferlay, J., Colombet, M., Piñeros, M., Znaor, A., Parkin, D. M., Soerjomataram, I., & Bray, F. (2024) · International Journal of Cancer · doi:10.1002/ijc.35278 · Cited by 1,079
Self-citationCancer incidence estimates for 2022 & projection for 2025
Sathishkumar, K., Chaturvedi, M., Das, P., Stephen, S., & Mathur, P. (2022) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1821_22 · Cited by 866
Morgan, E., Arnold, M., Camargo, M. C., Gini, A., Kunzmann, A. T., Matsuda, T., Meheus, F., Verhoeven, R. H. A., Vignat, J., Laversanne, M., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101404 · Cited by 806
Self-citationGenetic and molecular epidemiology of adult diffuse glioma
Molinaro, A. M., Taylor, J. W., Wiencke, J. K., & Wrensch, M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0220-2 · Cited by 731
The anti-cancer effect of quercetin: molecular implications in cancer metabolism
Reyes-Farias, M., & Carrasco-Pozo, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133177 · Cited by 689
“6 million deaths caused by cancer disease [1].”
BackgroundPizzato, M., Li, M., Vignat, J., Laversanne, M., Singh, D., Vecchia, C. L., & Vaccarella, S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00035-3 · Cited by 744
Makker, V., MacKay, H. J., Ray-Coquard, I. L., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 734
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Oaknin, A., Bosse, T., Creutzberg, C. L., Giornelli, G. H., Harter, P., Joly, F., Lorusso, D., Marth, C., Makker, V., Mirza, M. R., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.009 · Cited by 680
Dyba, T. A., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N. C., Gavin, A., Flego, M., Neamţiu, L., Dimitrova, N., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.07.039 · Cited by 690
Self-citationCA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 607
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
Arnold, M., Ferlay, J., Henegouwen, M. I. V. B., & Soerjomataram, I. (2020) · Gut · doi:10.1136/gutjnl-2020-321600 · Cited by 607
Self-citationAnjum, S., Hashim, M., Malik, S. A., Khan, M., Lorenzo, J. M., Abbasi, B. H., & Hano, C. (2021) · Cancers · doi:10.3390/cancers13184570 · Cited by 597
Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
Samaan, T. M. A., Samec, M., Líšková, A., Kubatka, P., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120789 · Cited by 595
Cervical cancer in low and middle‑income countries (Review)
Hull, R., Mbele, M., Makhafola, T. J., Hicks, C., Wang, S., Reis, R. M., Mehrotra, R., Mkhize‐Kwitshana, Z. L., Kibiki, G. S., Bates, D. O., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11754 · Cited by 614
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer
Huang, J., Lok, V., Ngai, C. H., Zhang, L., Yuan, J., Lao, X. Q., Ng, K. K., Chong, C. C. N., Zheng, Z., & Wong, M. C. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.007 · Cited by 539
Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
García-Pinel, B., Porras-Alcalá, C., Ortega-Rodríguez, A., Sarabia, F., Prados, J. C., Melguizo, C., & López‐Romero, J. M. (2019) · Nanomaterials · doi:10.3390/nano9040638 · Cited by 530
Chen, S., Zhu, G., Yang, Y., Wang, F., Xiao, Y., Zhang, N., Bian, X., Zhu, Y., Yu, Y., Liu, F., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00613-6 · Cited by 503
Epidemiology of stomach cancer
Ilić, M., & Ilić, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i12.1187 · Cited by 532
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Mathios, D., Johansen, J. S., Cristiano, S., Medina, J. E., Phallen, J. A., Larsen, K. R., Bruhm, D. C., Niknafs, N., Ferreira, L., Adleff, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24994-w · Cited by 476
Applications and Limitations of Dendrimers in Biomedicine
Chiş, A. A., Dobrea, C. M., Morgovan, C., Arseniu, A. M., Rus, L. L., Butucă, A., Juncan, A. M., Totan, M., Vonica-Țincu, A. L., Cormoș, G., et al. (2020) · Molecules · doi:10.3390/molecules25173982 · Cited by 490
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2020) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 457
Recent advances in selective photothermal therapy of tumor
Zhao, L., Zhang, X., Wang, X., Guan, X., Zhang, W., & Ma, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01080-3 · Cited by 446
Global patterns and trends in cancers of the lip, tongue and mouth
Miranda‐Filho, A., & Bray, F. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104551 · Cited by 474
Self-citationEstimativa de Incidência de Câncer no Brasil, 2023-2025
Santos, M. D. O., de Lima, F. C. D. S., Martins, L. F. L., Oliveira, J. F. P., de Almeida, L. M., & Cancela, M. D. C. (2023) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2023v69n1.3700 · Cited by 643
Priorities for cancer research in low- and middle-income countries: a global perspective
Pramesh, C. S., Badwe, R. A., Bhoo‐Pathy, N., Booth, C. M., Chinnaswamy, G., Dare, A. J., de Andrade, V. P., Hunter, D. J., Gopal, S., Gospodarowicz, M. K., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01738-x · Cited by 438
Estimating the total incidence of global childhood cancer: a simulation-based analysis
Ward, Z. J., Yeh, J. M., Bhakta, N. H., Frazier, A. L., & Atun, R. A. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30909-4 · Cited by 438
Moore, K. N., Bookman, M. A., Sehouli, J., Miller, A., Anderson, C. K., Scambia, G., Myers, T. K. N., Taşkıran, Ç., Robison, K. M., Maenpaa, J. U., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00306 · Cited by 417
Cancer in sub-Saharan Africa: a Lancet Oncology Commission
Ngwa, W. F., Addai, B. W., Adewole, I. F., Ainsworth, V., Alaro, J., Alatise, O. I., Ali, Z. V., Anderson, B. O., Anorlu, R. I., Avery, S., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00720-8 · Cited by 460
Force, L. M., Abdollahpour, I., Advani, S. M., Agius, D., Ahmadian, E., Alahdab, F., Alam, S., Alebel, A., Alipour, V., Allen, C. A., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30339-0 · Cited by 419
Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
Malki, A. M., Abu-El-Ruz, R., Gupta, I., Allouch, A., Vranić, S., & Moustafa, A. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010130 · Cited by 432
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Cortesi, L., Rugo, H. S., & Jackisch, C. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00796-4 · Cited by 411
Anticancer activities of TCM and their active components against tumor metastasis
Wang, K., Chen, Q., Shao, Y., Yin, S., Liu, C., Liu, Y., Wang, R., Wang, T., Qiu, Y., & Yu, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111044 · Cited by 385
van Hoogstraten, L. M. C., Vrieling, A., van der Heijden, A. G., Kogevinas, M., Richters, A., & Kiemeney, L. A. L. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00744-3 · Cited by 404
The multidisciplinary management of rectal cancer
Keller, D. S., Berho, M. E., Perez, R. O., Wexner, S. D., & Chand, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0275-y · Cited by 369
Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050
Pilleron, S., Soto‐Pérez‐de‐Celis, E., Vignat, J., Ferlay, J., Soerjomataram, I., Bray, F., & Sarfati, D. (2020) · International Journal of Cancer · doi:10.1002/ijc.33232 · Cited by 359
Self-citationAn updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer
Morze, J., Danielewicz, A., Przybyłowicz, K. E., Zeng, H., HOFFMANN, G. E., & Schwingshackl, L. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02346-6 · Cited by 375
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 368
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z., Teng, Q., Qin, T. L., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 338
Rahaman, M. M., Li, C., Yao, Y., Kulwa, F., Wu, X., Li, X., & Wang, Q. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104649 · Cited by 339
An overview of spirooxindole as a promising scaffold for novel drug discovery
Zhou, L., Qu, R., & Yang, G. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1733526 · Cited by 324
Curcumin and colorectal cancer: An update and current perspective on this natural medicine
Weng, W., & Goel, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.011 · Cited by 287
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
Aapro, M., Bossi, P., Dasari, A. N., Fallowfield, L. J., Gascón, P., Geller, M. A., Jordan, K., Kim, J. W., Martin, K., & Porzig, S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05539-1 · Cited by 335
Lipid alterations in chronic liver disease and liver cancer
Paul, B., Lewińska, M., & Andersen, J. B. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100479 · Cited by 326
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment
Ruffin, A. T., Li, H., Vujanovic, L. N., Zandberg, D. P., Ferris, R. L., & Bruno, T. C. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00531-9 · Cited by 326
Cancer Stem Cells and Radioresistance: DNA Repair and Beyond
Schulz, A., Meyer, F., Dubrovska, A., & Borgmann, K. (2019) · Cancers · doi:10.3390/cancers11060862 · Cited by 317
Huang, S., Yang, J., Shen, N., Xu, Q., & Zhao, Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.006 · Cited by 317
ctDNA as a cancer biomarker: A broad overview
Pessoa, L. S., Heringer, M., & Ferrer, V. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103109 · Cited by 311
Vaidya, J. S., Bulsara, M. K., Baum, M., Wenz, F. K., Massarut, S., Pigorsch, S. U., Alvarado, M. D., Douek, M., Saunders, C. M., Flyger, H. L., et al. (2020) · BMJ · doi:10.1136/bmj.m2836 · Cited by 292
Burden of Pancreatic Cancer: From Epidemiology to Practice
Khalaf, N., El-Serag, H. B., Abrams, H. R., & Thrift, A. P. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.054 · Cited by 308
The Roles of MicroRNA in Lung Cancer
Wu, K., Tsai, Y., Lien, C., Kuo, P., & Hung, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071611 · Cited by 287
Bray, F., Parkin, D. M., Gnangnon, F. H. R., Tshisimogo, G., Peko, J. F., Adoubi, I., Assefa, M., Bojang, L., Awuah, B., Koulibaly, M., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00270-4 · Cited by 304
Self-citationWang, S., Zheng, R., Li, J., Zeng, H., Li, L., Chen, R., Sun, K., Han, B., Bray, F., Wei, W., et al. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00366-7 · Cited by 312
Self-citationRecent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update
Schafer, E. J., Laversanne, M., Sung, H., Soerjomataram, I., Briganti, A., Dahut, W. L., Bray, F., & Jemal, A. (2024) · European Urology · doi:10.1016/j.eururo.2024.11.013 · Cited by 283
Self-citationLiquid biopsies: Potential and challenges
Heidrich, I., Ačkar, L., Mohammadi, P. M., & Pantel, K. (2020) · International Journal of Cancer · doi:10.1002/ijc.33217 · Cited by 284
Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
Gao, D., Guo, X., Zhang, X., Chen, S., Wang, Y., Chen, T., Huang, G. J., Gao, Y. F., Tian, Z., & Yang, Z. (2019) · Materials Today Bio · doi:10.1016/j.mtbio.2019.100035 · Cited by 275
Trends in cervical cancer incidence in sub-Saharan Africa
Jedy-Agba, E. E., Joko-Fru, W. Y., Liu, B., Buziba, N. G., Borok, M. Z., Korir, A., Masamba, L. P. L., Manraj, S. S., Finesse, A., Wabinga, H., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0831-9 · Cited by 278
Self-citationDietary fat, bile acid metabolism and colorectal cancer
Ocvirk, S., & O’Keefe, S. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.003 · Cited by 266
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
Okumura, S., Konishi, Y., Narukawa, M., Sugiura, Y., Yoshimoto, S., Arai, Y., Sato, S., Yoshida, Y., Tsuji, S., Uemura, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25965-x · Cited by 273
Strickler, J. H., Cercek, A., Siena, S., André, T., Ng, K., Van Cutsem, E., Wu, C., Paulson, A. S., Hubbard, J. M., Coveler, A. L., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00150-x · Cited by 259
Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Li, Q., Tie, Y., Alu, A., Ma, X., & Shi, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01297-0 · Cited by 291
Artificial Intelligence in Dermatology Image Analysis: Current Developments and Future Trends
Li, Z., Koban, K. C., Schenck, T. L., Giunta, R. E., Li, Q., & Sun, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226826 · Cited by 291
Biomarkers in Colorectal Cancer: Current Research and Future Prospects
Ogunwobi, O. O., Mahmood, F., & Akingboye, A. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155311 · Cited by 255
Role of nano-selenium in health and environment
Kumar, A., & Prasad, K. S. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.11.004 · Cited by 248
Thomas, A., Necchi, A., Muneer, A., Tobias‐Machado, M., Tran, A. T. H., Rompuy, A. V., Spiess, P. E., & Albersen, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00246-5 · Cited by 261
Loret, N., Denys, H. G., Tummers, P., & Berx, G. (2019) · Cancers · doi:10.3390/cancers11060838 · Cited by 250
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
Marino, P., Mininni, M., Deiana, G., Marino, G., Divella, R., Bochicchio, I., Giuliano, A., Lapadula, S., Lettini, A. R., & Sanseverino, F. (2024) · Nutrients · doi:10.3390/nu16060800 · Cited by 292
Overview of skin cancer types and prevalence rates across continents
Roky, A. H., Islam, M. M., Ahasan, A. M. F., Mostaq, M. S., Mahmud, M. Z., Amin, M. N., & Mahmud, M. A. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.08.002 · Cited by 239
Sharma, R., Aashima, A., Nanda, M., Fronterrè, C., Sewagudde, P., Ssentongo, A. E., Yenney, K., Arhin, N. D., Oh, J. S., Amponsah‐Manu, F., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.839835 · Cited by 254
The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy
Ramírez-Labrada, A., Isla, D., Artal, A., Arias, M. A., Rezusta, A., Pardo, J., & Gálvez, E. M. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.12.007 · Cited by 236
Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management
Samant, H. V., Amiri, H. S., & Zibari, G. B. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2020.02.08 · Cited by 234
Gilles, H., Garbutt, T., & Landrum, J. (2022) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2022.04.004 · Cited by 226
Demirtaş, C. Ö., D’Alessio, A., Rimassa, L., Sharma, R., & Pinato, D. J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100347 · Cited by 230
Current status of immune checkpoint inhibitors for gastric cancer
Kono, K., Nakajima, S., & Mimura, K. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01090-4 · Cited by 226
ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides
Schaduangrat, N., Nantasenamat, C., Prachayasittikul, V., & Shoombuatong, W. (2019) · Molecules · doi:10.3390/molecules24101973 · Cited by 220
Badwelan, M., Muaddi, H. A., Ahmed, A., Lee, K. T., & Tran, S. D. (2023) · Current Oncology · doi:10.3390/curroncol30040283 · Cited by 235
MoS2-based nanocomposites for cancer diagnosis and therapy
Wang, J.-L., Sui, L., Huang, J., Miao, L., Nie, Y., Wang, K., Yang, Z., Huang, Q., Gong, X., Nan, Y., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.021 · Cited by 216
Metabolic glycan labelling for cancer-targeted therapy
Wang, H., & Mooney, D. J. (2020) · Nature Chemistry · doi:10.1038/s41557-020-00587-w · Cited by 220
Zheng, X., Weigert, A., Reu, S., Günther, S., Mansouri, S., Bassaly, B., Gattenlöhner, S., Grimminger, F., Pullamsetti, S. S., Seeger, W., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0069 · Cited by 221
Microsatellite instability in Gastric Cancer: Between lights and shadows
Puliga, E., Corso, S., Pietrantonio, F., & Giordano, S. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102175 · Cited by 221
Lee, P.-C., Wu, C.-J., Hung, Y.-W., Lee, C. J., Chi, C.-T., Lee, I.-C., Yu-Lun, K., Chou, S.-H., Luo, J.-C., Hou, M.-C., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004779 · Cited by 217
Teixeira, A. F., ten Dijke, P., & Zhu, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00605 · Cited by 216
Oliver, A. L. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2021.12.001 · Cited by 217
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Wu, P., Gao, W. Q., Su, M., Nice, E. C., Zhang, W., Lin, J., & Xie, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641469 · Cited by 218
Seretis, A., Cividini, S., Markozannes, G., Tseretopoulou, X., López, D. S., Ntzani, E., & Tsilidis, K. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45014-4 · Cited by 212
Metadata
- Authors
- Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- World Health Organization (CH)
- University of Oxford (GB)
- Corresponding author
- Ferlay, J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2018-12-06
- Volume
- 144
- Issue
- 8
- Pages
- 1941-1953
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2895926103
- Cited by
- 7,553
- References
- 16
- Citations by year
- 2026: 251 · 2025: 513 · 2024: 812 · 2023: 978 · 2022: 1340 · 2021: 1805 · 2020: 1403 · 2019: 425 · 2018: 13
- FWCI
- 344.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- University of Leicester
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- cancer incidence, cancer mortality, non-melanoma skin cancer, uncertainty intervals, source bias, world regions
- MeSH terms
- Global Burden of Disease, Adolescent, Adult, Aged, Aged, 80 and over, Cause of Death, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Neoplasms, Risk Factors, Incidence, Survival Rate, Databases, Factual, Sex Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
